Home › Non-Hodgkin Lymphoma › New York › Greenburgh
Non-Hodgkin Lymphoma clinical trials in Greenburgh, NY
5 studies for Non-Hodgkin Lymphoma are looking for participants at sites in and around Greenburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RecruitingPhase 2
- Phelps Hospital, Sleepy Hollow · 4 mi away
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
RecruitingObservational study
- Memorial Sloan Kettering Bergen (Consent Only), Montvale · 9 mi away
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RecruitingPhase 1/2
- New York Medical College, Valhalla · 5 mi away
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
RecruitingPhase 2
- New York Medical College, Valhalla · 5 mi away
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
RecruitingPhase 2
- New York Medical College, Valhalla · 5 mi away
Non-Hodgkin Lymphoma trials in other cities
- New York City, NY31 studies
- Houston, TX31 studies
- Boston, MA26 studies
- Nashville, TN21 studies
- Philadelphia, PA20 studies
- Baldwin Park, CA19 studies
- Washington, DC18 studies
- Atlanta, GA18 studies
- Chicago, IL18 studies
- Milwaukee, WI18 studies
- Columbus, OH18 studies
- Dallas, TX17 studies
Other studies in Greenburgh
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer28 studies
- Acute Myeloid Leukemia18 studies
- Prostate Cancer17 studies
- Cancer (all types)17 studies
- Lung Cancer17 studies
- Multiple Myeloma13 studies
- Colorectal Cancer11 studies
- Metastatic Cancer11 studies
- Endometrial Cancer11 studies
- Bladder Cancer10 studies
- Lymphoma9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.